BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11425528)

  • 1. Biological evaluation of hepatitis C virus helicase inhibitors.
    Phoon CW; Ng PY; Ting AE; Yeo SL; Sim MM
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1647-50. PubMed ID: 11425528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon.
    Tani H; Akimitsu N; Fujita O; Matsuda Y; Miyata R; Tsuneda S; Igarashi M; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1054-9. PubMed ID: 19150342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
    Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
    Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
    Borowski P; Lang M; Haag A; Baier A
    Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of 1H-benzotriazole and 1H-benzimidazole analogues--inhibitors of the NTpase/helicase of HCV and of some related Flaviviridae.
    Bretner M; Baier A; Kopańska K; Najda A; Schoof A; Reinholz M; Lipniacki A; Piasek A; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2005; 16(5):315-26. PubMed ID: 16245647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses.
    Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
    Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
    J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
    Nishikawa F; Funaji K; Fukuda K; Nishikawa S
    Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP).
    Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T
    Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA helicase activity of the hepatitis C virus nonstructural protein 3.
    Gwack Y; Kim DW; Han JH; Choe J
    Eur J Biochem; 1997 Nov; 250(1):47-54. PubMed ID: 9431989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines.
    Wagner R; Larson DP; Beno DW; Bosse TD; Darbyshire JF; Gao Y; Gates BD; He W; Henry RF; Hernandez LE; Hutchinson DK; Jiang WW; Kati WM; Klein LL; Koev G; Kohlbrenner W; Krueger AC; Liu J; Liu Y; Long MA; Maring CJ; Masse SV; Middleton T; Montgomery DA; Pratt JK; Stuart P; Molla A; Kempf DJ
    J Med Chem; 2009 Mar; 52(6):1659-69. PubMed ID: 19226162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.
    Tani H; Fujita O; Furuta A; Matsuda Y; Miyata R; Akimitsu N; Tanaka J; Tsuneda S; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2010 Feb; 393(1):131-6. PubMed ID: 20117090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated strategies for identifying leads that target the NS3 helicase of the hepatitis C virus.
    LaPlante SR; Padyana AK; Abeywardane A; Bonneau P; Cartier M; Coulombe R; Jakalian A; Wildeson-Jones J; Li X; Liang S; McKercher G; White P; Zhang Q; Taylor SJ
    J Med Chem; 2014 Mar; 57(5):2074-90. PubMed ID: 24467709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
    Lim SK; Othman R; Yusof R; Heh CH
    Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
    Leivers AL; Tallant M; Shotwell JB; Dickerson S; Leivers MR; McDonald OB; Gobel J; Creech KL; Strum SL; Mathis A; Rogers S; Moore CB; Botyanszki J
    J Med Chem; 2014 Mar; 57(5):2091-106. PubMed ID: 23944386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein.
    Misialek S; Rajagopalan R; Stevens SK; Beigelman L; Seiwert SD; Kossen K
    Anal Biochem; 2009 Nov; 394(1):138-40. PubMed ID: 19591800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
    Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicase, a target for novel inhibitors of hepatitis C virus.
    Yao N; Weber PC
    Antivir Ther; 1998; 3(Suppl 3):93-7. PubMed ID: 10726059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D; Wang YS; Gesell JJ; Wyss DF
    J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.